Prices for six vital medicines have been lowered in Russia

Prices for six vital medicines have decreased in Russia. This was announced on March 7 by the Federal Antimonopoly Service (FAS) in the Telegram channel.

It is specified that we are talking about drugs for the treatment of obstructive respiratory tract diseases, bronchial asthma, anemia, lymphoma and leukemia. Drug prices were reduced by an average of 50% of the average cost of their sale in 2024.

Treatment — light: patients with COPD without disability ask to be given drugs

With a low degree of obstructive pulmonary disease, they are not allowed free therapy.

Earlier, on February 28, the Federal Antimonopoly Service agreed on prices for five essential and essential medicines included in the list. It was clarified that the prices of drugs were reduced by 19% of the average cost of their sale in 2024 and by 141% of the minimum prices in the reference countries for Russia.